Rowe JM - Search Results

1

The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma.

Peled A, Abraham M, Avivi I, Rowe JM, Beider K, Wald H, Tiomkin L, Ribakovsky L, Riback Y, Ramati Y, Aviel S, Galun E, Shaw HL, Eizenberg O, Hardan I, Shimoni A, Nagler A. Peled A, et al. Among authors: rowe jm. Clin Cancer Res. 2014 Jan 15;20(2):469-79. doi: 10.1158/1078-0432.CCR-13-1302. Epub 2013 Nov 18. Clin Cancer Res. 2014. PMID: 24246358 Clinical Trial.

2

Myelodysplastic syndrome and associated skin lesions: a review of the literature.

Avivi I, Rosenbaum H, Levy Y, Rowe J. Avivi I, et al. Leuk Res. 1999 Apr;23(4):323-30. doi: 10.1016/s0145-2126(98)00161-1. Leuk Res. 1999. PMID: 10229317 Review.

3

Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.

Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Blumenfeld Z, et al. Among authors: rowe jm. J Soc Gynecol Investig. 1999 Sep-Oct;6(5):229-39. doi: 10.1016/s1071-5576(99)00028-3. J Soc Gynecol Investig. 1999. PMID: 10554760 Review.

4

Fertility after treatment for Hodgkin's disease.

Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Blumenfeld Z, et al. Among authors: rowe jm. Ann Oncol. 2002;13 Suppl 1:138-47. doi: 10.1093/annonc/13.s1.138. Ann Oncol. 2002. PMID: 12078896 Free article. Review.

5

Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control.

Oren I, Zuckerman T, Avivi I, Finkelstein R, Yigla M, Rowe JM. Oren I, et al. Among authors: rowe jm. Bone Marrow Transplant. 2002 Aug;30(3):175-9. doi: 10.1038/sj.bmt.1703628. Bone Marrow Transplant. 2002. PMID: 12189536

6

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias.

Shimoni A, Kröger N, Zander AR, Rowe JM, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: rowe jm. Leukemia. 2003 Feb;17(2):290-7. doi: 10.1038/sj.leu.2402808. Leukemia. 2003. PMID: 12592325 Clinical Trial.

7

Stem cell transplantation in adult ALL patients.

Avivi I, Rowe JM, Goldstone AH. Avivi I, et al. Among authors: rowe jm. Best Pract Res Clin Haematol. 2002 Dec;15(4):653-74. doi: 10.1053/beha.2003.0232. Best Pract Res Clin Haematol. 2002. PMID: 12617869 Review.

8

Acute lymphocytic leukemia: role of hematopoietic stem cell transplantation in current management.

Avivi I, Rowe JM. Avivi I, et al. Among authors: rowe jm. Curr Opin Hematol. 2003 Nov;10(6):463-8. doi: 10.1097/00062752-200311000-00011. Curr Opin Hematol. 2003. PMID: 14564178 Review.

9

Stem cell transplantation post invasive fungal infection is a feasible task.

Avivi I, Oren I, Haddad N, Rowe JM, Dann EJ. Avivi I, et al. Among authors: rowe jm. Am J Hematol. 2004 Jan;75(1):6-11. doi: 10.1002/ajh.10447. Am J Hematol. 2004. PMID: 14695626 Free article.

10

Prognostic factors in acute myeloid leukemia.

Avivi I, Rowe JM. Avivi I, et al. Among authors: rowe jm. Curr Opin Hematol. 2005 Jan;12(1):62-7. doi: 10.1097/01.moh.0000148760.15412.df. Curr Opin Hematol. 2005. PMID: 15604893 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

486 results

Search Page